Developer docs
API playgroundTry for free, no card

Search company profiles

BioTalentum

Full company profile

uuid002odpu

Namestring
BioTalentum
Websiteurl
biotalentum.eu
Company typeenum
Private
Founded yearint
2005
Descriptiontext

BioTalentum Ltd. is a Hungarian for-profit biotechnology company founded in 2005 and headquartered in Gödöllő, Hungary. Per its firmographic description, the company specializes in biotechnology with a focus on stem cell research and regenerative medicine, suggesting an R&D-oriented profile rather than a commercial-stage therapeutics operation. With a headcount band of 11–50 employees, BioTalentum appears to operate as a small, specialist biotech — the kind of entity typically structured around grant-funded research, contract research services, academic collaborations, or pre-clinical pipeline development rather than large-scale product commercialization.

The company's website (biotalentum.eu) is the primary first-party source referenced; however, the available scrape of that URL returned only a loading/verification placeholder rather than substantive content, leaving product detail, technology platforms, pipeline assets, intellectual property, and commercial offerings unverified from first-party material. No management team, funding rounds, partnerships, awards, patents, customer logos, or pricing disclosures are present in the input data. The secondary news source referenced discusses the broader CRISPR gene editing market and an unrelated acquisition (Cellistic / Artisan Bio) and does not contain information about BioTalentum. Consequently, the business model — whether grant-funded, contract research, licensing, or product-based — cannot be confirmed from the supplied evidence. Investors should treat public-facing material as incomplete and prioritize direct diligence with company management before drawing conclusions about commercial traction, pipeline status, or revenue mechanics.

Short descriptiontext

BioTalentum Ltd. is a Hungarian private biotechnology company founded in 2005, specializing in stem cell research and regenerative medicine, operating with 11–50 employees from Gödöllő, Hungary.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGodollo, Hungary
HQ citystring
Godollo
HQ countrystring
Hungary
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
stem cell research, regenerative medicine, biotechnology services, cell therapy development, tissue engineering
Industry3 codes
PRIMARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAL
Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Commercial Physical & Biological Research8731
Product category
Regenerative Medicine and Stem Cell Research Services
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BioTalentum Ltd. operates as a biotechnology company specializing in stem cell research and regenerative medicine. The firm develops cell-based technologies and regenerative therapies, serving research and life-sciences clients with stem cell-related expertise and laboratory services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Based on the provided sources, no specific product or service information is available. The website source shows only a loading/verification page, and the news source discusses general CRISPR market trends without detailing BioTalentum's product portfolio.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Global contract development and manufacturing organization with major cell-and-gene-therapy services. Comparable to BioTalentum as an enabling organization in the cell therapy manufacturing chain, but operating at vastly larger scale across multiple modalities.

TypeEmerging player
Description

Emerging iPSC-derived allogeneic cell therapy developer. Comparable to BioTalentum in its use of stem cell platforms for therapeutic development, though at a much more advanced and better-funded stage.

TypeDirect peer
Description

Specialty provider of cell culture media, separation products, and instruments for stem cell research. Comparable to BioTalentum as a stem-cell-focused life-sciences organization, but operating in research tools rather than therapeutics.

TypeBroad incumbent
Description

Large CDMO with dedicated cell therapy manufacturing capabilities. Comparable to BioTalentum as a participant in the regenerative medicine manufacturing ecosystem, though as an incumbent with broad biopharma services rather than a specialized stem cell developer.

TypeDirect peer
Description

iPSC-derived cell therapy and cell model company combining stem cell biology with coding-based cell specification. Comparable to BioTalentum through its core reliance on stem cell / iPSC technology for therapeutic and research applications.

TypeDirect peer
Description

Clinical-stage cell and gene therapy company working on allogeneic CAR-T and genome-edited cell therapies. Comparable to BioTalentum as a stem-cell-adjacent cell therapy platform developer.

TypeDirect peer
Description

Commercial-stage cell therapy company with an approved stem-cell-derived product (Omisirge). Comparable to BioTalentum as a stem cell therapy developer with a path to commercialized regenerative medicine.

TypeDirect peer
Description

Clinical-stage regenerative medicine company developing mesenchymal lineage cell therapies. Directly comparable to BioTalentum as a stem-cell-derived therapeutics developer, but at a far more advanced commercial and clinical stage.

TypeDirect peer
Description

Developer and manufacturer of iPSC-derived cell products for research, drug discovery, and cell therapy. Directly comparable to BioTalentum through its iPSC and stem cell differentiation focus.

10Pluristem Therapeutics
TypeDirect peer
Description

Develops placenta-derived, off-the-shelf cell therapies. Comparable as a stem-cell-focused regenerative medicine developer with platform-cell ambitions similar in spirit to BioTalentum's stem cell focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioTalentum

Regenerative Medicine and Stem Cell Research Servicesbiotalentum.eu

BioTalentum Ltd. is a Hungarian private biotechnology company founded in 2005, specializing in stem cell research and regenerative medicine, operating with 11–50 employees from Gödöllő, Hungary.

What BioTalentum does

BioTalentum Ltd. is a Hungarian for-profit biotechnology company founded in 2005 and headquartered in Gödöllő, Hungary. Per its firmographic description, the company specializes in biotechnology with a focus on stem cell research and regenerative medicine, suggesting an R&D-oriented profile rather than a commercial-stage therapeutics operation. With a headcount band of 11–50 employees, BioTalentum appears to operate as a small, specialist biotech — the kind of entity typically structured around grant-funded research, contract research services, academic collaborations, or pre-clinical pipeline development rather than large-scale product commercialization.

The company's website (biotalentum.eu) is the primary first-party source referenced; however, the available scrape of that URL returned only a loading/verification placeholder rather than substantive content, leaving product detail, technology platforms, pipeline assets, intellectual property, and commercial offerings unverified from first-party material. No management team, funding rounds, partnerships, awards, patents, customer logos, or pricing disclosures are present in the input data. The secondary news source referenced discusses the broader CRISPR gene editing market and an unrelated acquisition (Cellistic / Artisan Bio) and does not contain information about BioTalentum. Consequently, the business model — whether grant-funded, contract research, licensing, or product-based — cannot be confirmed from the supplied evidence. Investors should treat public-facing material as incomplete and prioritize direct diligence with company management before drawing conclusions about commercial traction, pipeline status, or revenue mechanics.

BioTalentum firmographics

Firmographics
Name
BioTalentum
Website
https://biotalentum.eu
Company type
Private
Founded year
2005
Headcount range
11–50 employees
Short description
BioTalentum Ltd. is a Hungarian private biotechnology company founded in 2005, specializing in stem cell research and regenerative medicine, operating with 11–50 employees from Gödöllő, Hungary.
Ownership category
akta.pro rank

BioTalentum industry classification

Industry
Product category
Regenerative Medicine and Stem Cell Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAGAA
Stem Cell–Based Regenerative Therapies
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAL
Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Stem cell research
  • Regenerative medicine
  • Biotechnology services
  • Cell therapy development
  • Tissue engineering

Where BioTalentum is headquartered

Location

Headquarters

HQ city
Godollo
HQ country
Hungary
HQ region
Europe

Markets served

BioTalentum business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

BioTalentum product offering

Product offering

Core offering

BioTalentum Ltd. operates as a biotechnology company specializing in stem cell research and regenerative medicine. The firm develops cell-based technologies and regenerative therapies, serving research and life-sciences clients with stem cell-related expertise and laboratory services.

Product overview

Based on the provided sources, no specific product or service information is available. The website source shows only a loading/verification page, and the news source discusses general CRISPR market trends without detailing BioTalentum's product portfolio.

Differentiator

Problem solved

Functional benefit

Companies that use BioTalentum

Customer profile

Ideal customer profiles1 record

BioTalentum technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioTalentum partnerships and signals

Strategic signal

Recent moves1 record

BioTalentum competitors and assessment

Company assessment

Broad incumbents

  • Lonza: Global contract development and manufacturing organization with major cell-and-gene-therapy services. Comparable to BioTalentum as an enabling organization in the cell therapy manufacturing chain, but operating at vastly larger scale across multiple modalities.
  • Catalent: Large CDMO with dedicated cell therapy manufacturing capabilities. Comparable to BioTalentum as a participant in the regenerative medicine manufacturing ecosystem, though as an incumbent with broad biopharma services rather than a specialized stem cell developer.

Emerging players

  • Century Therapeutics: Emerging iPSC-derived allogeneic cell therapy developer. Comparable to BioTalentum in its use of stem cell platforms for therapeutic development, though at a much more advanced and better-funded stage.

Direct peers

  • Stemcell Technologies: Specialty provider of cell culture media, separation products, and instruments for stem cell research. Comparable to BioTalentum as a stem-cell-focused life-sciences organization, but operating in research tools rather than therapeutics.
  • bit.bio: iPSC-derived cell therapy and cell model company combining stem cell biology with coding-based cell specification. Comparable to BioTalentum through its core reliance on stem cell / iPSC technology for therapeutic and research applications.
  • Cellectis: Clinical-stage cell and gene therapy company working on allogeneic CAR-T and genome-edited cell therapies. Comparable to BioTalentum as a stem-cell-adjacent cell therapy platform developer.
  • Gamida Cell: Commercial-stage cell therapy company with an approved stem-cell-derived product (Omisirge). Comparable to BioTalentum as a stem cell therapy developer with a path to commercialized regenerative medicine.
  • Mesoblast: Clinical-stage regenerative medicine company developing mesenchymal lineage cell therapies. Directly comparable to BioTalentum as a stem-cell-derived therapeutics developer, but at a far more advanced commercial and clinical stage.
  • Cellular Dynamics International (FUJIFILM CDI): Developer and manufacturer of iPSC-derived cell products for research, drug discovery, and cell therapy. Directly comparable to BioTalentum through its iPSC and stem cell differentiation focus.
  • Pluristem Therapeutics: Develops placenta-derived, off-the-shelf cell therapies. Comparable as a stem-cell-focused regenerative medicine developer with platform-cell ambitions similar in spirit to BioTalentum's stem cell focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

BioTalentum social profiles

Digital presence

BioTalentum financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioTalentum leadership team

Management profile

Number of profiles

BioTalentum funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioTalentum M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioTalentum

What does BioTalentum do?

BioTalentum Ltd. operates as a biotechnology company specializing in stem cell research and regenerative medicine. The firm develops cell-based technologies and regenerative therapies, serving research and life-sciences clients with stem cell-related expertise and laboratory services.

When was BioTalentum founded?

BioTalentum was founded in 2005. It employs 11 to 50 people.

Where is BioTalentum based?

BioTalentum is headquartered in Godollo, Hungary, in the Europe region.

Who are BioTalentum's main competitors?

Broad incumbents on record are Lonza and Catalent. Century Therapeutics is listed as an emerging player. Direct peers are Stemcell Technologies, bit.bio, Cellectis, Gamida Cell, Mesoblast, Cellular Dynamics International (FUJIFILM CDI) and Pluristem Therapeutics.

Does BioTalentum have an API?

No public API is recorded for BioTalentum.

What industry is BioTalentum in?

BioTalentum's product category is Regenerative Medicine and Stem Cell Research Services. Its primary akta.pro industry code is HLAAAGAA, Stem Cell–Based Regenerative Therapies, with a secondary code of HLAAAGAL, Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics). Its NAICS code is 541714 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales